Skip to main content

Table 2 Linear regression analysis between R21X carrier status and Lp(a) levels

From: Investigation of a nonsense mutation located in the complex KIV-2 copy number variation region of apolipoprotein(a) in 10,910 individuals

Population

Carriers [n]

n

β*

95% CI lower bound*

95% CI upper bound*

SE*

p

R2†

I2||

GCKD

74

4771

− 13.0‡§

− 20.0

− 6.0

3.6

4.34e−12

0.011

KORA F3

56

3099

− 12.6

− 19.5

− 5.7

3.5

6.50e−11

0.013

KORA F4

63

3040

− 9.9

− 16.0

− 3.8

3.1

3.95e−12

0.015

Meta-analysis

193

10,910

− 11.7

− 15.5

− 7.8

1.9

3.39e−32

0.0

  1. Lp(a) concentrations are given as mg/dL. The β estimate is given on the original scale (mg/dL). Age- and sex-adjusted model
  2. n number
  3. *On the original scale
  4. On the inverse normal transformed scale
  5. GCKD additionally adjusted for eGFR: beta = − 12.4 [− 19.58; − 5.25], SE = 3.7, p = 3.16e−10
  6. §GCKD additionally adjusted for eGFR and urine albumin-to-creatinine ratio: beta = − 13.12 [− 20.22; − 6.02], SE = 3.6, p = 1.08e−10
  7. ||Heterogeneity was 0.0 on the original and on the inverse normal transformed scales